Circulating antibody secreting cells and humoral antibody response after parenteral immunization with a meningococcal polysaccharide vaccine

Scandinavian Journal of Infectious Diseases

Volumn 28, Issue 1, 1996, Pages 53-58

  Nieminen, Tea ^a   Käyhty, Helena ^a   Kantele, Anu ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HUMORAL ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNIZATION; MALE; NORMAL HUMAN; SECRETORY CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029869596     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549609027150     Document Type: Article

References (19)

1. Lue C, van den Wall Blake AW, Prince SJ, Julian BA, Tseng ML, Radl J, Elson CO, Mestecky J. Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibidy-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin Exp Immunol 96: 356-363, 1994.
2. 2-subclass antibody responses. J Immunol 144: 3770-3778, 1990.
3. Trollmo C, Sollerman C, Carlsten H, Tarkowsky A. The gut as an inductive site for synovial and extra articular immune responses in rheumatoid arthritis. Ann Rheum Dis 53: 377-382, 1994.
4. Waldman RH, Lazzell VA, Bergman C, Khakoo R, Jacknowictz AI, Howard SA, Rose C. Oral immunization against influenza. Trans Am Clin Climatol Assoc 93: 133-140, 1982.
5. Waldman RH, Bergman K-C. Oral immunization against respiratory tract pathogens. Allergie et Immunologie 16: 135-139, 1994
6. Lue C, Tarkowski A, Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol 140: 3793-3800, 1988.
7. Kantele A, Arvilommi H, Kantele JM, Rintala L, Mäkelä PH. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi Ty21a vaccines. Microb Pathogen 10: 117-126, 1991.
8. Pichichero M, Insel R. Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. J Allergy Clin Immunol 72: 481-486, 1983.
9. Peltola H. Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis 10: 41-44, 1978.
10. Arakere G, Frasch CE. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers. Inf Imm 59: 4349-4356, 1991.
11. Mäkelä PH, Peltola H, Käyhtu H, Jousimies H, Pettay O, Ruoslahti E, Sivonen A, Renkonen O-V. Polysaccharide vaccines of group A Neisseria meningitis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis 136 Suppl: S43-S50, 1977.
12. Gotschlich EC, Rey M, Triau R, Sparks KJ. Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest 51: 89-96, 1972.
13. Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody secreting cells. J Immunol Meth 57: 301-309, 1983.
14. Käyhty H, Mäkelä O, Eskola J, Saarinen L, Seppälä I. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus Influenzae type b vaccines at 18 to 24 months of age. J Infect Dis 158: 209-212, 1988.
15. Bienenstock J, Befus AD, McDermot M, Mirski S, Rosenthal K. Regulation of lymphoblast traffic and localization in mucosal tissues with emphasis on IgA. Fed Proc 42: 3213-3217, 1983.
16. Stroffolini T, Angelini L, Galanti I, Occhionero M, Congiu ME, Mastrantonio P. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carriage state. Microbiologica 13: 225-229, 1990.
17. Robbins JB. Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future. Immunochemistry 15: 839-854, 1987.
18. Zangwill KM, Stout DRW, Carlone GM, Pais L, Harekeh H, Mitchell S, Wolfe WH, Blackwood V, Plikaytis BD, Wengner JD. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis 169: 847-852, 1994.
19. Goldschneider I, Lepow ML, Gotschlich EC, Mauck FT, Bachi F, Randolph M. Immunogenicity of group A and group C meningococcal polysaccharides in infants. J Infect Dis 128: 769-776, 1973